Literature DB >> 11292340

A novel mutation in the neurofibromatosis type 1 (NF1) gene promotes skipping of two exons by preventing exon definition.

L J Fang1, M J Simard, D Vidaud, B Assouline, B Lemieux, M Vidaud, B Chabot, J P Thirion.   

Abstract

Using a protein truncation assay, we have identified a new mutation in the neurofibromatosis type 1 (NF1) gene that causes a severe defect in NF1 pre-mRNA splicing. The mutation, which consists of a G to A transition at position +1 of the 5' splice site of exon 12a, is associated with the loss of both exons 11 and 12a in the NF1 mRNA. Through the use of in vivo and in vitro splicing assays, we show that the mutation inactivates the 5' splice site of exon 12a, and prevents the definition of exon 12a, a process that is normally required to stimulate the weak 3' splice site of exon 12a. Because the 5' splice site mutation weakens the interaction of splicing factors with the 3' splice site of exon 12a, we propose that exon 11/exon 12a splicing is also compromised, leading to the exclusion of both exons 11 and 12a. Our results provide in vivo support for the importance of the exon definition model during NF1 splicing, and suggest that the NF1 region containing exons 11 and 12a plays an important role in the activity of neurofibromin. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292340     DOI: 10.1006/jmbi.2001.4561

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Novel double-deletion mutations of the OFD1 gene creating multiple novel transcripts.

Authors:  Takeshi Morisawa; Mariko Yagi; Agus Surono; Naoki Yokoyama; Makoto Ohmori; Hiroto Terashi; Masafumi Matsuo
Journal:  Hum Genet       Date:  2004-06-02       Impact factor: 4.132

2.  In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.

Authors:  Natalia N Singh; Elliot J Androphy; Ravindra N Singh
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

3.  A novel splice variant in the N-propeptide of COL5A1 causes an EDS phenotype with severe kyphoscoliosis and eye involvement.

Authors:  Sofie Symoens; Fransiska Malfait; Philip Vlummens; Trinh Hermanns-Lê; Delfien Syx; Anne De Paepe
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

4.  Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.

Authors:  Kazuhiko Takahara; Ulrike Schwarze; Yasutada Imamura; Guy G Hoffman; Helga Toriello; Lynne T Smith; Peter H Byers; Daniel S Greenspan
Journal:  Am J Hum Genet       Date:  2002-07-17       Impact factor: 11.025

5.  Specific variants in WDR35 cause a distinctive form of Ellis-van Creveld syndrome by disrupting the recruitment of the EvC complex and SMO into the cilium.

Authors:  José A Caparrós-Martín; Alessandro De Luca; François Cartault; Mona Aglan; Samia Temtamy; Ghada A Otaify; Mennat Mehrez; María Valencia; Laura Vázquez; Jean-Luc Alessandri; Julián Nevado; Inmaculada Rueda-Arenas; Karen E Heath; Maria Cristina Digilio; Bruno Dallapiccola; Judith A Goodship; Pleasantine Mill; Pablo Lapunzina; Victor L Ruiz-Perez
Journal:  Hum Mol Genet       Date:  2015-04-23       Impact factor: 6.150

6.  CAGI experiments: Modeling sequence variant impact on gene splicing using predictions from computational tools.

Authors:  Valer Gotea; Gennady Margolin; Laura Elnitski
Journal:  Hum Mutat       Date:  2019-06-27       Impact factor: 4.700

Review 7.  Splicing mutations in human genetic disorders: examples, detection, and confirmation.

Authors:  Abramowicz Anna; Gos Monika
Journal:  J Appl Genet       Date:  2018-04-21       Impact factor: 3.240

8.  The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.

Authors:  Gudrun Wahlström; Samuel Heron; Matias Knuuttila; Elina Kaikkonen; Nea Tulonen; Olli Metsälä; Christoffer Löf; Otto Ettala; Peter J Boström; Pekka Taimen; Matti Poutanen; Johanna Schleutker
Journal:  Hum Mol Genet       Date:  2022-06-22       Impact factor: 5.121

9.  Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.

Authors:  Eva Machackova; Lenka Foretova; Mirka Lukesova; Petra Vasickova; Marie Navratilova; Ilse Coene; Hana Pavlu; Veronika Kosinova; Jitka Kuklova; Kathleen Claes
Journal:  BMC Cancer       Date:  2008-05-20       Impact factor: 4.430

10.  Two-exon skipping within MLPH is associated with coat color dilution in rabbits.

Authors:  Stefanie Lehner; Marion Gähle; Claudia Dierks; Ricarda Stelter; Jonathan Gerber; Ralph Brehm; Ottmar Distl
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.